Short Interest in Owens & Minor, Inc. (NYSE:OMI) Increases By 29.1%

Owens & Minor, Inc. (NYSE:OMI) was the recipient of a large growth in short interest during the month of July. As of July 15th, there was short interest totalling 4,130,000 shares, a growth of 29.1% from the June 30th total of 3,200,000 shares. Based on an average daily trading volume, of 906,800 shares, the short-interest ratio is presently 4.6 days. Approximately 5.9% of the shares of the company are short sold.

Insider Activity

In related news, EVP Heath H. Galloway sold 2,031 shares of Owens & Minor stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $20.18, for a total value of $40,985.58. Following the completion of the sale, the executive vice president now owns 56,898 shares of the company’s stock, valued at approximately $1,148,201.64. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other news, Director Mark A. Beck sold 9,344 shares of the firm’s stock in a transaction on Wednesday, June 5th. The stock was sold at an average price of $17.25, for a total value of $161,184.00. Following the completion of the transaction, the director now directly owns 11,154 shares of the company’s stock, valued at $192,406.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Heath H. Galloway sold 2,031 shares of the business’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $20.18, for a total value of $40,985.58. Following the sale, the executive vice president now owns 56,898 shares in the company, valued at $1,148,201.64. The disclosure for this sale can be found here. Insiders have sold 31,923 shares of company stock valued at $562,711 in the last 90 days. Insiders own 3.59% of the company’s stock.

Hedge Funds Weigh In On Owens & Minor

A number of institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. grew its holdings in shares of Owens & Minor by 1.9% during the 1st quarter. Vanguard Group Inc. now owns 8,749,866 shares of the company’s stock worth $242,459,000 after acquiring an additional 162,182 shares during the period. Dimensional Fund Advisors LP grew its stake in Owens & Minor by 8.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 4,210,991 shares of the company’s stock worth $81,148,000 after purchasing an additional 327,002 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in Owens & Minor by 4.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 825,142 shares of the company’s stock worth $15,900,000 after purchasing an additional 38,393 shares in the last quarter. Bridgeway Capital Management LLC lifted its position in Owens & Minor by 11.8% during the first quarter. Bridgeway Capital Management LLC now owns 591,174 shares of the company’s stock valued at $16,381,000 after buying an additional 62,509 shares during the period. Finally, Epoch Investment Partners Inc. boosted its holdings in shares of Owens & Minor by 27.2% during the 1st quarter. Epoch Investment Partners Inc. now owns 530,434 shares of the company’s stock valued at $14,698,000 after buying an additional 113,587 shares in the last quarter. 98.04% of the stock is owned by institutional investors.

Owens & Minor Price Performance

Shares of NYSE:OMI opened at $15.43 on Tuesday. The stock has a market cap of $1.18 billion, a PE ratio of -30.25, a PEG ratio of 0.49 and a beta of 0.25. The company’s fifty day moving average is $15.70 and its 200 day moving average is $20.36. Owens & Minor has a 52 week low of $12.36 and a 52 week high of $28.35. The company has a quick ratio of 0.56, a current ratio of 1.16 and a debt-to-equity ratio of 2.17.

Owens & Minor (NYSE:OMI) last released its quarterly earnings data on Friday, May 3rd. The company reported $0.19 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.02. The firm had revenue of $2.61 billion during the quarter, compared to analyst estimates of $2.61 billion. Owens & Minor had a positive return on equity of 12.97% and a negative net margin of 0.37%. The business’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.05 earnings per share. Research analysts anticipate that Owens & Minor will post 1.54 earnings per share for the current year.

Analyst Ratings Changes

OMI has been the topic of a number of recent analyst reports. Bank of America lowered their price target on shares of Owens & Minor from $18.00 to $16.00 and set an “underperform” rating on the stock in a report on Tuesday, June 25th. StockNews.com downgraded shares of Owens & Minor from a “buy” rating to a “hold” rating in a report on Thursday, May 23rd. Robert W. Baird reduced their price target on shares of Owens & Minor from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Tuesday, July 16th. Finally, Citigroup upgraded Owens & Minor from a “neutral” rating to a “buy” rating and lowered their price objective for the stock from $24.00 to $19.00 in a research report on Friday, July 19th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, Owens & Minor currently has a consensus rating of “Hold” and an average target price of $20.63.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.